TrialEuropean journal of clinical pharmacology2015

A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes.

Ivan Tkáč et al.PubMed ↗Publisher ↗

No numbers read from the abstract.